Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma

Published:2018-08-01 Issue:17 Volume:124 Page:3520-3527
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Brand Randall¹,Borazanci Erkut²,Speare Virginia³^ORCID,Dudley Beth¹^ORCID,Karloski Eve¹,Peters Mary Linton B.⁴^ORCID,Stobie Lindsey⁴,Bahary Nathan¹,Zeh Herbert⁵,Zureikat Amer⁵,Hogg Melissa⁵,Lee Kenneth⁵,Tsung Allan⁵,Rhee John¹,Ohr James¹,Sun Weijing⁶,Lee James¹,Moser A. James⁴,DeLeonardis Kim⁴,Krejdovsky Jill⁴,Dalton Emily³,LaDuca Holly³,Dolinsky Jill³,Colvin Arlene²,Lim Cynthia²,Black Mary Helen³,Tung Nadine⁴

Affiliation:

1. Department of Medicine; University of Pittsburgh Medical Center; Pittsburgh Pennsylvania

2. HonorHealth; Scottsdale Arizona

3. Ambry Genetics; Aliso Viejo California

4. Beth Israel Deaconess Medical Center; Boston Massachusetts

5. Department of Surgery; University of Pittsburgh Medical Center; Pittsburgh Pennsylvania

6. Division of Medical Oncology; University of Kansas; Kansas City Kansas

Funder

Scottish Alliance for Geoscience, Environment and Society

Ambry Genetics provided administrative support for the study and genetic testing at no fee to the institution, patient or insurance

Publisher

Wiley